Jun 29 2023 30 mins 2
To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630
Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.
Educational Objectives
- Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care
- List strategies to individualize patient care and improve recommendations for AD
Moderator:
Mary Bridgeman, PharmD, BCPS, BCGP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
Faculty & Caregiver:
Ashley Ellis, PharmD, MBA, CDECS
ImPAcT Director & Assistant Professor
The University of Tennessee Health Science Center
Department of Clinical Pharmacy and Translation Science College of Pharmacy
Memphis, Tennessee
Mary Bridgeman, PharmD, BCPS, BCGP has no financial relationships with commercial interests to disclose.
Ashley Ellis, PharmD, MBA, CDECS, has the following financial relationships with commercial interests to disclose:
Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars
Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through June 30, 2024.
This activity is supported by an educational grant from CeraVe and La Roche-Posay.
Brought to you in partnership with the National Eczema Association.
